Skip to main content

IM Cannabis Corp.

IMCC
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001792030

No open-market purchases or sales by IM Cannabis Corp. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $62.0K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding IM Cannabis Corp. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of IMCC: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders20117−2
Shares525.7K2816.2K+290.6K (+55.3%)
Value$517.6K$2$261.7K−$256.0K (−49.4%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held IM Cannabis Corp. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to IMCC in Q1 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC14,678$11.0K0.00%
StoneX Group Inc.10,091$7.22K0.00%
National Bank of Canada98$670.00%
Lynwood Capital Management Inc.455,000––

Sold out (6)

Institutions that held IM Cannabis Corp. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of IMCC in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Wasatch Advisors Inc140,052$138.7K
Black Maple Capital Management LP98,729$96.2K
Baader Bank INC63,500$61.9K
Jane Street Group, LLC14,468$14.1K
Edmond de Rothschild Holding S.A.1,057$1.01K
UBS Group AG2$2

Not filed for Q1 2023 yet (1)

Institutions that held IM Cannabis Corp. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMCC in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
CoreCap Advisors, LLC2$2